Patent · US Active

Car t-cells comprising inactivated CBL and CBL-B genes

US12187780B2 · kind B2 · utility

0Cited by
0References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 23, 2018
Grant dateJan 7, 2025
Priority date
Expiry dateDec 20, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/14
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods and compositions for treating cancer, particularly improved CAR-T methods, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.